[go: up one dir, main page]

FI943545L - Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla - Google Patents

Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla Download PDF

Info

Publication number
FI943545L
FI943545L FI943545A FI943545A FI943545L FI 943545 L FI943545 L FI 943545L FI 943545 A FI943545 A FI 943545A FI 943545 A FI943545 A FI 943545A FI 943545 L FI943545 L FI 943545L
Authority
FI
Finland
Prior art keywords
virus
anion exchange
exchange chromatography
factor viii
highly purified
Prior art date
Application number
FI943545A
Other languages
English (en)
Swedish (sv)
Other versions
FI943545A0 (fi
FI109908B (fi
Inventor
Monika Stadler
Horst Schwinn
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6451895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI943545(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI943545A0 publication Critical patent/FI943545A0/fi
Publication of FI943545L publication Critical patent/FI943545L/fi
Application granted granted Critical
Publication of FI109908B publication Critical patent/FI109908B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI943545A 1992-02-01 1994-07-28 Menetelmä erittäin puhtaan, virusinaktivoidun tekijän VIII ja von Willebrand -tekijän kompleksin saamiseksi talteen anioninvaihtokromatografian avulla FI109908B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4204694 1992-02-01
DE4204694A DE4204694C3 (de) 1992-02-01 1992-02-01 Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
PCT/EP1993/000114 WO1993015105A1 (en) 1992-02-01 1993-01-20 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
EP9300114 1993-01-20

Publications (3)

Publication Number Publication Date
FI943545A0 FI943545A0 (fi) 1994-07-28
FI943545L true FI943545L (fi) 1994-07-28
FI109908B FI109908B (fi) 2002-10-31

Family

ID=6451895

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943545A FI109908B (fi) 1992-02-01 1994-07-28 Menetelmä erittäin puhtaan, virusinaktivoidun tekijän VIII ja von Willebrand -tekijän kompleksin saamiseksi talteen anioninvaihtokromatografian avulla

Country Status (16)

Country Link
US (1) US5714590A (fi)
EP (1) EP0625161B9 (fi)
JP (1) JP3556947B2 (fi)
KR (1) KR100240310B1 (fi)
AT (1) ATE203249T1 (fi)
AU (1) AU670776B2 (fi)
DE (2) DE4204694C3 (fi)
DK (1) DK0625161T4 (fi)
ES (1) ES2157920T5 (fi)
FI (1) FI109908B (fi)
GR (1) GR3036849T3 (fi)
NO (1) NO315426B1 (fi)
PT (1) PT625161E (fi)
RU (1) RU2096414C1 (fi)
TW (1) TW362099B (fi)
WO (1) WO1993015105A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0602173B1 (en) * 1991-09-05 1999-05-26 Baxter International Inc. Topical fibrinogen complex
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
RU2253475C1 (ru) * 2004-02-02 2005-06-10 Общество с ограниченной ответственностью "Гемоцентр" Способ получения препарата фактора viii
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
RU2293570C2 (ru) * 2005-02-01 2007-02-20 Государственное учреждение Гематологический научный центр РАМН (ГУ ГНЦ РАМН) Способ обогащения фактором viii криопреципитата плазмы донорской крови
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
RU2579977C2 (ru) * 2009-11-13 2016-04-10 Грифольс Терапьютикс Инк. СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE3811042A1 (de) * 1988-03-31 1989-10-19 Merck Patent Gmbh Ionenaustauscher
EP0343275B1 (de) * 1988-05-27 1993-02-03 Centre Regional De Transfusion Sanguine De Lille Verfahren zur Herstellung eines hochreinen, virusfreien Antihämophiliefaktors mittels Chromatographie
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
ES2053684T3 (es) * 1988-11-05 1994-08-01 Octapharma Ag Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
DE4204694C3 (de) 1995-10-12
TW362099B (en) 1999-06-21
RU2096414C1 (ru) 1997-11-20
ES2157920T5 (es) 2007-12-16
FI943545A0 (fi) 1994-07-28
KR950700925A (ko) 1995-02-20
NO942832D0 (no) 1994-07-29
EP0625161B2 (en) 2007-05-16
DE4204694C2 (de) 1994-02-10
EP0625161A1 (en) 1994-11-23
DE69330458D1 (de) 2001-08-23
JP3556947B2 (ja) 2004-08-25
FI109908B (fi) 2002-10-31
EP0625161B9 (en) 2007-09-19
JPH07503241A (ja) 1995-04-06
ATE203249T1 (de) 2001-08-15
US5714590A (en) 1998-02-03
AU670776B2 (en) 1996-08-01
WO1993015105A1 (en) 1993-08-05
GR3036849T3 (en) 2002-01-31
DK0625161T4 (da) 2007-09-03
EP0625161B1 (en) 2001-07-18
NO942832L (no) 1994-07-29
DK0625161T3 (da) 2001-09-24
NO315426B1 (no) 2003-09-01
KR100240310B1 (ko) 2000-01-15
DE69330458T2 (de) 2002-05-29
DE69330458T3 (de) 2008-01-17
PT625161E (pt) 2001-10-31
DE4204694A1 (de) 1993-08-12
AU3351793A (en) 1993-09-01
ES2157920T3 (es) 2001-09-01

Similar Documents

Publication Publication Date Title
FI961071L (fi) Menetelmä zeoliitin valmistamiseksi
ITTV940010A0 (it) Struttura di nasello, particolarmente per montature di occhiali
FI970680L (fi) Menetelmä polyhydroksilakaanihapon talteenottamiseksi
FI20000648A7 (fi) Menetelmä terapeuttisesti käyttökelpoisen yhdisteen valmistamiseksi, joka sisältää 1-okso-2-isokinoliiniin perustuvan keskuksen
FI943545L (fi) Menetelmä tekijän VIII, jonka puhtausaste on korkea ja josta virukset on inaktivoitu, saamiseksi talteen anioninvaihtokromatografian avulla
FI941395A7 (fi) Menetelmä karbonylointituotteen talteenottamiseksi
ITTO950250A0 (it) Montatura perfezionata per occhiali.
AU6080698A (en) Method for purifying factor viii/vwf complex by cation-exchange chromatography
EP0592229A3 (en) Multi-error correction method.
FI940032A7 (fi) Menetelmä bifenyylijohdannaisten valmistamiseksi
FI912102A7 (fi) Menetelmä 2,6-di-isopropyylifenolin puhdistamiseksi
FI960429L (fi) Menetelmä 1,4-butaanidiolin valmistamiseksi
FI20041691L (fi) Menetelmä kasvainten vastaisten tioksantenoniyhdisteiden valmistamiseksi
FI961900L (fi) Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä
FI960332A7 (fi) Menetelmä substituoitujan 4,6-diamino-5-syanopyrinidiinien valmistamiseksi
IT1267623B1 (it) Telaio per macchine cingolate.
AU1811195A (en) Process for extracting highly purified, virus-inactivated alpha1-anti-trypsin by anion exchanger chromatography
FI960568L (fi) Menetelmä metallien talteenottamiseksi
ITTO920895A1 (it) Proiettore, particolarmente per veicoli.
ITMI921634A1 (it) Impianto di spazzamento per macchine per la manutenzione dei binari
ITTO910127A0 (it) Metodo per il recupero dei reagenti di base per la sintesi di vetri zblan da soluzioni purificate
ITRE930078A0 (it) Impianto di frenatura tipicamente per trattori.
ES1026621Y (es) Mensula auxilar para andamios.
IT211482Z2 (it) Montatura metallica per occhiali costituita da particolari graffe.
FI922665A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
MM Patent lapsed